text.skipToContent text.skipToNavigation
Pharma & Biotech

SABMTM Small Airway Epithelial Cell Growth Basal Medium

Catalog #: CC-3119
SABMTM Small Airway Epithelial Basal Medium
Compare
EA

Product Overview

SABMTM is a basal medium sold separately. This is used as a component in the full SAGMTM Small Airway Epithelial Cell Growth Medium BulletKitTM (catalog number CC-3118) which consists of basal and supplements packaged together. SAGMTM BulletKitTM is serum-free and has been optimized to grow human small airway epithelial cells (SAEC).

Content & Storage

Content

1 x Bottle Basal Medium 500 mL

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Co-culture Experiments with Lonza's Small Airway Epithelial Cells and SAGMTM BulletKitTM Media

Data Courtesy of Furukawa, et al. Lonza's SAEC cells were co-cultured with primary normal mammary epithelial cells, breast cancer cell lines MCF-7 and MDA-MB-231 in Lonza's SAGMTM BulletKitTM Growth Media. Breast cancer cell lines showed differences in morphology and proliferation rates in the presence of small airway epithelial cells. The image above shows phase contrast imaging with a fluorescent (red) overlay of MCF-7 cell line. MCF-7 cell lines survived as tight clusters in SAGMTM Media. When co-cultured with Lonza's primary SAECs, MCF-7 cells demonstrated enhanced growth all the while staying clustered.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Interested in our Webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Need a Quote or Any Support?

Are Lonza's primary cells and media applicable to your project? Do you need a quote or any help? Contact us and a local representative will get back to you.

We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok